$XBI $71.09 | +3.83%
Table of Contents:
$INO +13.7% INOVIO Announces Survival Results for INO-5401 + INO-9012 in Combination with Libtayo® (cemiplimab) in Patients with Newly Diagnosed GBM at ASCO Annual Meeting 2022 source
$TIL -24.3% Instil Bio Announces IND Clearance of First CoStAR-TIL program, ITIL-306, Designed to Enhance Activity in the Tumor Microenvironment source
$AMRX -0.9% Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRA™ (pegfilgrastim-pbbk) source
Want to get weekly catalyst updates?
*We never spam you - unsubscribe anytime*
Posted by JM